A programme in rural Kenya and Uganda that has already demonstrated that a dynamic, person-centred HIV prevention intervention results in substantial increases in the numbers of people covered by PrEP or PEP, has now shown the added benefits of offering a choice between PrEP pills and PrEP injections.
When services were offered in the usual way, a minority of people used oral PrEP or PEP. When services were optimised to provide choice and flexibility, uptake more than doubled. And in the latest stage of the randomised study – with the additional option of PrEP injections – 70% of people used some form of biomedical HIV prevention.
Read the full story at Aidsmap.
SEE ALSO:
Source : Aidsmap
Related HIV and Co-Infections News
-
[Press release] US and Global Fund expand commitment to long-acting HIV prevention as country rollout of lenacapavir accelerates
-
University of Manchester: Scientists develop a cheaper and more sustainable way to manufacture breakthrough HIV drug lenacapavir
-
EL PAÍS: US aid cuts collapse Malawi’s LGBTQ+ health services as volunteers scramble to fill the void
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.